AI Therapeutics Company

AI Therapeutics develops drugs for rare diseases and cancer.

Last Funding Type: Series C
Funding Status: M&A
Headquarters: Guilford, Connecticut, United States
Founded Date: 2013-01-01
Investor Type: info@lamthera.com
Investment Stage: N/A
Last Funding Date: 2017-03-30
Total Funding: 98000000
Technology: ['BioTech & HealthTech']
Employee Number: 51-100
Number Of Exists: N/A
Estimated Revenue: $1M to $10M
Investors Number: 2.0
Industry: Medical BioTech